↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Germany TED / Vergabe.de contract award · ocds-ted-153149-2024

Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs

DAK-Gesundheit awarded €1 to Novartis Pharma GmbH for Healthcare & Medical in March 2024 — one of 389 awards this buyer has made, in line with its typical award size.

Healthcare & Medical
13 Mar 2024
Award date
€1
Contract value

Buying agency

DAK-Gesundheit
389 Awards
€581K Avg award
Typical vs typical

Winning supplier

Novartis Pharma GmbH
41 Awards
4 Buyers
€3 Total won

Contract description

Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs - Kesimpta (Wirkstoff: Ofatumumab), ATC L04AA52

Premium

Related awards · DAK-Gesundheit

389 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

345 more awards from this buyer · full history & CSV export

Premium

Other wins · Novartis Pharma GmbH

41 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for DAK-Gesundheit and Novartis Pharma GmbH — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up